CHEBI:70746 - dabigatran etexilate

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name dabigatran etexilate
ChEBI ID CHEBI:70746
Definition An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amino group of ethyl N-pyridin-2-yl-β-alaninate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
Formula C34H41N7O5
Net Charge 0
Average Mass 627.73320
Monoisotopic Mass 627.317
InChI InChI=1S/C34H41N7O5/c1-4-6-7-10-21-46-34(44)39-32(35)24-12-15-26(16-13-24)37-23-30-38-27-22-25(14-17-28(27)40(30)3)33(43)41(20-18-31(42)45-5-2)29-11-8-9-19-36-29/h8-9,11-17,19,22,37H,4-7,10,18,20-21,23H2,1-3H3,(H2,35,39,44)
InChIKey KSGXQBZTULBEEQ-UHFFFAOYSA-N
SMILES CCCCCCOC(=O)\N=C(\N)c1ccc(NCc2nc3cc(ccc3n2C)C(=O)N(CCC(=O)OCC)c2ccccn2)cc1
Roles Classification
Biological Role(s): EC 3.4.21.5 (thrombin) inhibitor
An EC 3.4.21.* (serine endopeptidase) inhibitor that interferes with the action of thrombin (EC 3.4.21.5).
Application(s): anticoagulant
An agent that prevents blood clotting.
prodrug
A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing dabigatran etexilate (CHEBI:70746) has functional parent dabigatran (CHEBI:70752)
dabigatran etexilate (CHEBI:70746) has role anticoagulant (CHEBI:50249)
dabigatran etexilate (CHEBI:70746) has role EC 3.4.21.5 (thrombin) inhibitor (CHEBI:65232)
dabigatran etexilate (CHEBI:70746) has role prodrug (CHEBI:50266)
dabigatran etexilate (CHEBI:70746) is a β-alanine derivative (CHEBI:22823)
dabigatran etexilate (CHEBI:70746) is a aromatic amide (CHEBI:62733)
dabigatran etexilate (CHEBI:70746) is a benzimidazoles (CHEBI:22715)
dabigatran etexilate (CHEBI:70746) is a carboxamidine (CHEBI:35359)
dabigatran etexilate (CHEBI:70746) is a carboxylic ester (CHEBI:33308)
dabigatran etexilate (CHEBI:70746) is a pyridines (CHEBI:26421)
dabigatran etexilate (CHEBI:70746) is conjugate base of dabigatran etexilate(1+) (CHEBI:70751)
Incoming dabigatran etexilate(1+) (CHEBI:70751) is conjugate acid of dabigatran etexilate (CHEBI:70746)
IUPAC Name
ethyl N-[(2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl]-N-pyridin-2-yl-β-alaninate
INN Source
dabigatran etexilate KEGG DRUG
Manual Xrefs Databases
776 DrugCentral
D07144 KEGG DRUG
HMDB0015641 HMDB
US2011275824 Patent
WO2007047608 Patent
WO2011061080 Patent
WO2012027543 Patent
WO2012077136 Patent
View more database links
Registry Numbers Types Sources
15496119 Reaxys Registry Number Reaxys
211915-06-9 CAS Registry Number KEGG DRUG
211915-06-9 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
21265583 PubMed citation Europe PMC
21429525 PubMed citation Europe PMC
21542663 PubMed citation Europe PMC
21748501 PubMed citation Europe PMC
21859976 PubMed citation Europe PMC
21881389 PubMed citation Europe PMC
22252796 PubMed citation Europe PMC
22276081 PubMed citation Europe PMC
22298812 PubMed citation Europe PMC
22318514 PubMed citation Europe PMC
22348256 PubMed citation Europe PMC
22422743 PubMed citation Europe PMC
22431533 PubMed citation Europe PMC
22488474 PubMed citation Europe PMC
22536678 PubMed citation Europe PMC
22552763 PubMed citation Europe PMC
22563715 PubMed citation Europe PMC
22564134 PubMed citation Europe PMC
22669799 PubMed citation Europe PMC
22782539 PubMed citation Europe PMC
22803489 PubMed citation Europe PMC
22995531 PubMed citation Europe PMC
23476049 PubMed citation Europe PMC
Last Modified
22 February 2017